The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Lupus Patients Have More Lethal Form of Kidney Disease

Lupus Patients Have More Lethal Form of Kidney Disease

April 13, 2011 • By Sue Pondrom

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Children and adults with end-stage renal disease (ESRD) secondary to systemic lupus erythematosus (SLE) have a higher risk of death than those with other types of kidney disease, according to a study by Sule et al.1

You Might Also Like
  • Mortality Trends in Lupus Nephritis
  • Kidney Problems More Prevalent in Patients with Rheumatoid Arthritis
  • Cardiovascular Disease Rate Differs Between SLE Patients of Different Races, Ethnicities
Also By This Author
  • Arthritis in Winter

Based on an analysis of United States Renal Data System records from more than 98,000 children and adults with various forms of ESRD (not limited to SLE), the researchers found that kidney disease in children with SLE was more than twice (2.4 times) as lethal compared with pediatric patients with ESRD secondary to other causes. Adult SLE patients had a 1.7 times–higher risk of dying than adults with other forms of ESRD.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In both pediatric and adult SLE populations, the vast majority of deaths were attributed to cardiovascular disease; however, the affects were primarily noted in children. Three quarters of the children with SLE kidney disease who died did so from heart problems, mostly heart attacks. By comparison, only 26% of children with nonlupus kidney disease died from heart problems.

The researchers said that SLE triggers chronic inflammation and that lupus patients seem more likely to develop hypertension and high cholesterol at an unusually early age. “Inflammation may play a pathological role in the development of cardiovascular disease,” they commented, adding that “an increased inflammatory state leading to atherosclerosis may account for the much young age at death for the adult patients with ESRD secondary SLE compared with other patients.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“What we may be seeing here is a double whammy of cardiovascular damage—on the one hand, there’s the damage caused by lupus itself, further compounded by the resulting kidney disease,” said lead investigator Sangeeta Sule, MD, PhD, a pediatric nephrologist and SLE expert at Johns Hopkins Childrens Center in Maryland, in a news release.

While 75% of deaths in children were attributed to heart disease, 25% were attributed to septicemia/infections. These causes accounted for half of deaths in adults with ESRD secondary to SLE, as well—30% from cardiovascular disease and 20% from infections. In adult and pediatric patients with other causes of ESRD, cardiovascular disease and infections were also common causes of death, at 25% and 8% of adult deaths and 26% and 12% of pediatric deaths, respectively.

Rheumatologists Weigh In

“It would be interesting to see if there is a difference in mortality rates among the adult onset dialysis patients with SLE if their SLE began before or after age 18,” according to a written comment to The Rheumatologist from rheumatologists Anne Eberhard, MD, of North Shore-Long Island Jewish Health System, and Emily von Scheven, MD, of the University of California, San Francisco.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: Renal disease, Research, Systemic lupus erythematosus

You Might Also Like:
  • Mortality Trends in Lupus Nephritis
  • Kidney Problems More Prevalent in Patients with Rheumatoid Arthritis
  • Cardiovascular Disease Rate Differs Between SLE Patients of Different Races, Ethnicities
  • Biomarkers, Genetic Clues to Higher Cardiovascular Disease Risk in Patients with Lupus

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.